相关实验视频
Updated: Jan 24, 2026

09:56
Cochlear Implantation in the Guinea Pig
Published on: June 15, 2018
11.8K
重复中剂量红色激光辐射对几内亚猪眼组织的影响
Qian-Qian Song1, Wenjun Xu1, Shi-Ming Li1
1Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Science Key Lab, Beijing, People's Republic of China.
Investigative ophthalmology & visual science
|January 23, 2026
概括
重复暴露于红色激光会损害几内亚猪视网膜,导致外核层 (ONL) 和视网膜色素上皮 (RPE) 的细胞死亡. 这项研究强调了视网膜是红色激光辐射的脆弱目标.
科学领域:
- 眼科医生 眼科 眼科
- 激光医学是激光医学.
- 细胞生物学 细胞生物学
背景情况:
- 红色激光辐射用于各种医疗应用.
- 了解重复激光照射对眼睛的影响对于安全至关重要.
研究的目的:
- 研究重复红色激光照射对几内亚猪眼组织的组织学和分子效应.
- 为了识别特定的眼睛结构易受红色激光照射.
主要方法:
- 在8天的时间里,几内亚猪接受了重复的红色激光 (650nm,10mW) 疗程.
- 组织病理学,TUNEL测定,免疫组织化学和分子分析 (西斑,qPCR) 进行.
- 测量了亡标记物 (Caspase-3,Caspase-9,Bax,Bcl-2) 和RPE65的数量.
主要成果:
- 红色激光暴露导致视网膜病变,包括外核层 (ONL) 皮克诺斯和光受体退化.
- 在ONL中显著增加了亡细胞,并改变了与亡相关的标记物的表达 (Bax,Bcl-2,Caspase-3).
- 视网膜色素上皮 (RPE) 显示连续性被破坏,并减少了RPE65表达.
结论:
- 以超临床剂量的重复红色激光照射会损害视网膜,特别是ONL,光受体和RPE.
- 视网膜被确定为一个易受攻击的目标,而前段结构仍然不受影响.
- 这些发现提供了对红色激光暴露在眼睛组织上的潜在风险的见解.
相关概念视频
Dose Size and Dosing Frequency: Determination Methods
285
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
285
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
230
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
230
Red Algae
796
Red algae, also known as rhodophytes, are primarily found in marine environments, though some species inhabit freshwater and terrestrial ecosystems. These organisms exist in both unicellular and multicellular forms, with some multicellular varieties reaching macroscopic sizes.As phototrophic organisms, red algae contain chlorophyll a; however, their chloroplasts lack chlorophyll b. Instead, they possess phycobiliproteins, which serve as major light-harvesting pigments, similar to those found in...
796
Rational Dosage Regimen: Maintenance Dose and Loading Dose
5.4K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.4K
Dose-Response Relationship: Overview
5.0K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.0K
Drug Dosing: Infants and Children
265
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
265

